Tower Research Capital (TRC)’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,848
Closed -$848 6383
2023
Q3
$848 Sell
5,848
-1,565
-21% -$2.33K ﹤0.01% 5461
2023
Q2
$17.3K Buy
7,413
+3,144
+74% +$5.84K ﹤0.01% 3508
2023
Q1
$7K Buy
+4,269
New +$11K ﹤0.01% 4801
2022
Q4
Sell
-20
Closed 6629
2022
Q3
$0 Sell
20
-5,222
-100% -$31.5K ﹤0.01% 6718
2022
Q2
$69K Buy
5,242
+4,836
+1,191% +$28.5K ﹤0.01% 2600
2022
Q1
$1K Buy
+406
New +$2.09K ﹤0.01% 5935

Other funds holding MKUL

Tower Research Capital (TRC)'s MKUL Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Molekule Group, Inc. Common Stock (MKUL) in Q4 2023, closing a stake of 5,848 shares — an estimated $848 sold.

Tower Research Capital (TRC) first reported a position in MKUL in Q1 2022 and held it in 6 quarters. The position peaked at $69K in Q2 2022. 3 funds tracked by Wall St. Rank hold MKUL as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining Molekule Group, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,848 Molekule Group, Inc. Common Stock shares in Q4 2023, an estimated $848.
  • Tower Research Capital (TRC) first reported a position in Molekule Group, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s Molekule Group, Inc. Common Stock position peaked at $69K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.